(Q43682481)

English

Report of three cases of hyperlactacidemiae/lactic acidosis after treatment of hepatitis C with pegylated interferon and ribavirin in HIV coinfected patients

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Report of three cases of hyperlactacidemiae/lactic acidosis after treatment of hepatitis C with pegylated interferon and ribavirin in HIV coinfected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

author name string

M L Montes Ramírez

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M Rodríguez Zapata

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Revista Clínica Española

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

202

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

543-545

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Correlates of hepatitis C virus infections among injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2565%2802%2971139-9

7 January 2021

Management of chronic hepatitis C in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2565%2802%2971139-9

7 January 2021

Natural history of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2565%2802%2971139-9

7 January 2021

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2565%2802%2971139-9

7 January 2021

The progression of HCV-associated liver disease in a cohort of haemophilic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2565%2802%2971139-9

7 January 2021

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2565%2802%2971139-9

7 January 2021

Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2565%2802%2971139-9

7 January 2021

Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2565%2802%2971139-9

7 January 2021

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2565%2802%2971139-9

7 January 2021

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2565%2802%2971139-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0014-2565(02)71139-9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43682481&oldid=2102481406"